NINDS Cooperative Program in Translational Research Multi-Component Research Projects (U54)

archived

-Purpose. The goal of this funding opportunity announcement (FOA) is to support pre-clinical development and testing of new therapies for neurological disorders.The program will facilitate solicitation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing.This program is specifically directed at projects that include therapeutic leads with demonstrated activity against the intended disease target.The program supports pre-clinical optimization and testing of these leads and projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as high throughput screening.The program also excludes clinical research, basic research, and studies of disease mechanism.This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress. -Mechanism of Support. This FOA will utilize the U54 Specialized Center Cooperative Agreements grant mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.

High